AU4017389A - Use of paf-antagonists for treating autoimmune diseases - Google Patents

Use of paf-antagonists for treating autoimmune diseases

Info

Publication number
AU4017389A
AU4017389A AU40173/89A AU4017389A AU4017389A AU 4017389 A AU4017389 A AU 4017389A AU 40173/89 A AU40173/89 A AU 40173/89A AU 4017389 A AU4017389 A AU 4017389A AU 4017389 A AU4017389 A AU 4017389A
Authority
AU
Australia
Prior art keywords
paf
antagonists
autoimmune diseases
treating autoimmune
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU40173/89A
Other versions
AU627763B2 (en
Inventor
Helmet Lohmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU4017389A publication Critical patent/AU4017389A/en
Application granted granted Critical
Publication of AU627763B2 publication Critical patent/AU627763B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40173/89A 1988-08-24 1989-08-24 Use of PAF-antagonists for treating autoimmune diseases Ceased AU627763B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3828678 1988-08-24
DE3828678 1988-08-24

Publications (2)

Publication Number Publication Date
AU4017389A true AU4017389A (en) 1990-03-01
AU627763B2 AU627763B2 (en) 1992-09-03

Family

ID=6361480

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40173/89A Ceased AU627763B2 (en) 1988-08-24 1989-08-24 Use of PAF-antagonists for treating autoimmune diseases

Country Status (11)

Country Link
EP (1) EP0361077A3 (en)
JP (1) JPH03500898A (en)
KR (1) KR900701276A (en)
AU (1) AU627763B2 (en)
DK (1) DK95890D0 (en)
HU (1) HUT59604A (en)
IL (1) IL91386A0 (en)
NZ (1) NZ230406A (en)
PH (1) PH26996A (en)
WO (1) WO1990001927A2 (en)
ZA (1) ZA896422B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605689A (en) * 1991-05-31 1997-02-25 Genentech, Inc. Treatment of HIV-associated immune thrombocytopenic purpura

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
JP3060287B2 (en) * 1995-10-09 2000-07-10 参天製薬株式会社 Aqueous eye drops containing apaphant as the main drug
AU6517398A (en) * 1997-03-27 1998-10-22 Kyowa Hakko Kogyo Co. Ltd. Therapeutic agent for autoimmune diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591596B1 (en) * 1985-12-13 1988-09-09 Roussel Uclaf NOVEL 4H-TRIAZOLO (4,3-A) (1,4) BENZODIAZEPINES, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
ES2037013T3 (en) * 1986-01-21 1993-06-16 Boehringer Ingelheim Kg PROCEDURE FOR PREPARING TIENO-1,4-DIAZEPINES.
DE3610848A1 (en) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg NEW 1,4-DIAZEPINE
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines
DE3710921C2 (en) * 1986-10-21 1996-09-26 Korth Ruth Use of Gingkolide BN 52020, BN 52021 and BN 52063 for the treatment of arteriosclerosis
EP0268242B1 (en) * 1986-11-17 1992-03-18 Yoshitomi Pharmaceutical Industries, Ltd. Paf-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605689A (en) * 1991-05-31 1997-02-25 Genentech, Inc. Treatment of HIV-associated immune thrombocytopenic purpura

Also Published As

Publication number Publication date
HUT59604A (en) 1992-06-29
WO1990001927A2 (en) 1990-03-08
AU627763B2 (en) 1992-09-03
WO1990001927A3 (en) 1990-05-17
NZ230406A (en) 1992-03-26
ZA896422B (en) 1991-04-24
JPH03500898A (en) 1991-02-28
DK95890A (en) 1990-04-18
PH26996A (en) 1993-02-01
IL91386A0 (en) 1990-04-29
EP0361077A2 (en) 1990-04-04
KR900701276A (en) 1990-12-01
HU896004D0 (en) 1990-11-28
EP0361077A3 (en) 1990-07-11
DK95890D0 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
AU1928388A (en) Surgical dressing
AU2189588A (en) Artificial skin
AU4620789A (en) Treatment of obesity
AU1374288A (en) Skin substitute
AU1676588A (en) Treatment of materials
AU6434390A (en) Treatment of ards
AU2262988A (en) Natural feeling condom
AU580820B2 (en) Treatment of obesity
GB2223959B (en) Treatment of nitrophenolic by-products
AU2027388A (en) Tissue put-up
AU3604289A (en) Treatment of arthritis
AU1427188A (en) Elastic bandage
US5011841B1 (en) Treatment of depression
AU2720388A (en) New therapeutical use of h2-receptor-blocking compounds
AU4017389A (en) Use of paf-antagonists for treating autoimmune diseases
GB2215214B (en) Surgical dressing
AU6414190A (en) Treatment of carbohydrates
AU7167591A (en) Treatment of hsv
AU2297088A (en) Improved ovulation treatment
GB2247031B (en) Reinforcement of tissue
GB8802421D0 (en) Set of parts
AU8083591A (en) Therapy and prophylaxis of autoimmune diseases
AU7695891A (en) Treatment of autoimmune diseases
AU4603289A (en) Novel treatment
AU3502189A (en) Use of diazepinones